<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genomics Inform</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genomics Inform</journal-id>
      <journal-title-group>
        <journal-title>Genomics &amp; Informatics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1598-866X</issn>
      <issn pub-type="epub">2234-0742</issn>
      <publisher>
        <publisher-name>Korea Genome Organization</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30602079</article-id>
      <article-id pub-id-type="pmc">6440676</article-id>
      <article-id pub-id-type="doi">10.5808/GI.2018.16.4.e18</article-id>
      <article-id pub-id-type="publisher-id">gi-2018-16-4-e18</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Roles of Oncogenic Long Non-coding RNAs in Cancer Development</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0229-2986</contrib-id>
          <name>
            <surname>Do</surname>
            <given-names>Hyunhee</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7611-5248</contrib-id>
          <name>
            <surname>Kim</surname>
            <given-names>Wanyeon</given-names>
          </name>
          <xref ref-type="corresp" rid="c1-gi-2018-16-4-e18">*</xref>
        </contrib>
        <aff id="af1-gi-2018-16-4-e18">Department of Biology Education, Korea National University of Education, Cheongju 28173, <country>Korea</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-gi-2018-16-4-e18"><label>*</label>Corresponding author: Tel: +82-43-230-3750, Fax: +82-43-232-7176, E-mail: <email>wykim82@knue.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>12</month>
        <year>2018</year>
      </pub-date>
      <volume>16</volume>
      <issue>4</issue>
      <elocation-id>e18</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>11</month>
          <year>2018</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>11</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>11</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2018 by Korea Genome Organization</copyright-statement>
        <copyright-year>2018</copyright-year>
        <license>
          <license-p>It is identical to the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Long non-coding RNAs (lncRNAs) are classified as RNAs that are longer than 200 nucleotides and cannot be translated into protein. Several studies have demonstrated that lncRNAs are directly or indirectly involved in a variety of biological processes and in the regulation of gene expression. In addition, lncRNAs have important roles in many diseases including cancer. It has been shown that abnormal expression of lncRNAs is observed in several human solid tumors. Several studies have shown that many lncRNAs can function as oncogenes in cancer development through the induction of cell cycle progression, cell proliferation and invasion, anti-apoptosis, and metastasis. Oncogenic lncRNAs have the potential to become promising biomarkers and might be potent prognostic targets in cancer therapy. However, the biological and molecular mechanisms of lncRNA involvement in tumorigenesis have not yet been fully elucidated. This review summarizes studies on the regulatory and functional roles of oncogenic lncRNAs in the development and progression of various types of cancer.</p>
      </abstract>
      <kwd-group>
        <kwd>breast cancer</kwd>
        <kwd>colorectal cancer</kwd>
        <kwd>glioblastoma</kwd>
        <kwd>long non-coding RNA</kwd>
        <kwd>non-small cell lung cancer</kwd>
        <kwd>oncogenes</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Upon completion of the Human Genome Project, it was revealed that only 2% of the human genome including protein-coding genes [<xref rid="b1-gi-2018-16-4-e18" ref-type="bibr">1</xref>]. In the past, non-coding RNAs (ncRNAs) were deemed so-called useless or &#x2018;junk&#x2019; DNA. But, as a result of the Encyclopedia of DNA Elements (ENCODE) project, it was found that ncRNAs have specific functions in a variety of biological processes [<xref rid="b2-gi-2018-16-4-e18" ref-type="bibr">2</xref>]. Moreover, it has been shown that 98% of ncRNAs are involved in various cellular functions including chromatin remodeling, transcription, alternative splicing and translational regulation.</p>
      <p>In addition, there are several types of ncRNAs including small non-coding RNAs (sncRNAs), microRNAs (miRNAs), and small nucleolar RNAs. Recently, it was reported long non-coding RNAs (lncRNAs) that were different from sncRNAs [<xref rid="b3-gi-2018-16-4-e18" ref-type="bibr">3</xref>]. The classification standard for sncRNAs and lncRNAs is based on nucleotide (nt) length, and the length criterion for sncRNAs was less than 200 nt while the length of lncRNAs was more than 200 nt [<xref rid="b4-gi-2018-16-4-e18" ref-type="bibr">4</xref>]. Accumulated clues have been reported that lncRNAs have important roles in many biological processes such as cell growth and differentiation, chromatin composition, and the regulation of gene expression by directly or indirectly participating in transcription and translation, indicating that lncRNAs could act as functional genes [<xref rid="b5-gi-2018-16-4-e18" ref-type="bibr">5</xref>]. Thus, there are many efforts conducted by many oncologists to identify and analyze lncRNAs as novel functional genes responsible for tumorigenesis and cancer development. It has been revealed that some of lncRNAs act as oncogenes highly associated with the hallmarks of cancer such as cell cycle progression, anti-apoptosis, angiogenesis, and metastasis [<xref rid="b6-gi-2018-16-4-e18" ref-type="bibr">6</xref>&#x2013;<xref rid="b8-gi-2018-16-4-e18" ref-type="bibr">8</xref>]. In this review, we discuss the roles of lncRNAs in biological processes and describe the lncRNA-mediated signaling pathways involved in cancers, with a focus on oncogenic lncRNAs.</p>
    </sec>
    <sec>
      <title>Long Non-coding RNAs</title>
      <p>Based on the location and orientation on the chromosome, lncRNAs are subdivided as intergenic lncRNAs, intronic lncRNAs, bidirectional lncRNAs, sense overlapping lncRNAs, and antisense RNAs (<xref ref-type="fig" rid="f1-gi-2018-16-4-e18">Fig. 1</xref>) [<xref rid="b9-gi-2018-16-4-e18" ref-type="bibr">9</xref>, <xref rid="b10-gi-2018-16-4-e18" ref-type="bibr">10</xref>]. Briefly, an intergenic lncRNA locates between two protein-coding genes more than 1 kb away from each other. An intronic lncRNA is placed on the intron region of a protein coding gene in either sense or antisense direction. A biodirectional lncRNA is oriented from the opposite direction within 1 kb of the promoter for the protein-coding gene. In particular, when a protein-coding gene is transcribed, a biodirectional lncRNA counterpart tends to be transcribed as well. It suggests that they might share regulatory factors for the transcription. A sense overlapping lncRNA overlaps with a protein-coding gene on the same DNA strand for its transcription. Since this type of lncRNA extensively lacks the open reading frame for the translation, it can be distinguished from a transcript variant of the protein-coding mRNAs. An antisense lncRNA can be transcribed from the antisense DNA strand of a protein-coding gene. Despite several types of lncRNAs, they are highly probable to have been transcribed by RNA polymerase II, capping, splicing, and polyadenylation [<xref rid="b11-gi-2018-16-4-e18" ref-type="bibr">11</xref>]. They are also controlled by transcription activators and repressors. However, it has been reported that lncRNAs have limited coding potential.</p>
      <p>LncRNAs have different roles in nucleus and cytoplasm (<xref ref-type="fig" rid="f2-gi-2018-16-4-e18">Fig. 2</xref>). The lncRNAs in the nucleus function as chromatin remodeling and transcription guides and are active in the regulation of transcription factors (TFs) and TF-associated factors, as well as the regulation of pre-mRNA splicing and miRNA processing [<xref rid="b12-gi-2018-16-4-e18" ref-type="bibr">12</xref>]. LncRNAs in the cytoplasm function as competing endogenous RNAs (ceRNAs) acting as molecular sponges for miRNAs, targeting proteins to regulate their expression, and suppressing translation by targeting mRNAs [<xref rid="b13-gi-2018-16-4-e18" ref-type="bibr">13</xref>]. In addition to their various roles in cells, lncRNAs are also involved in various human diseases including cardiovascular diseases, autoimmune diseases, neurodegenerative disorders, and psychiatric disorders [<xref rid="b10-gi-2018-16-4-e18" ref-type="bibr">10</xref>, <xref rid="b14-gi-2018-16-4-e18" ref-type="bibr">14</xref>, <xref rid="b15-gi-2018-16-4-e18" ref-type="bibr">15</xref>]. In particular, lncRNAs are reported to be closely associated with tumorigenesis [<xref rid="b8-gi-2018-16-4-e18" ref-type="bibr">8</xref>]. Many lncRNAs act as oncogenic genes in the development of cancer through the regulation of metastasis, cell death suppression, and cell growth, as well they affect the DNA damage response through their relationships with various genes [<xref rid="b16-gi-2018-16-4-e18" ref-type="bibr">16</xref>]. In the next section, we demonstrate the functions of cancer-related oncogenic lncRNAs in lung cancer, colorectal cancer, glioblastoma, and breast cancer.</p>
    </sec>
    <sec>
      <title>Oncogenic lncRNAs</title>
      <sec>
        <title>Non-small cell lung cancer</title>
        <p>Lung cancer is the leading cause of cancer-related deaths in the world [<xref rid="b17-gi-2018-16-4-e18" ref-type="bibr">17</xref>]. Eighty-five percent of lung cancer is classified as non-small cell lung cancer (NSCLC) and the remaining 15% is categorized as small-cell lung cancer [<xref rid="b18-gi-2018-16-4-e18" ref-type="bibr">18</xref>]. Approximately 70% of NSCLC patients are diagnosed at an advanced cancer metastatic state and their 5-year probability of survival is approximately 14% [<xref rid="b19-gi-2018-16-4-e18" ref-type="bibr">19</xref>]. Various lncRNAs have been implicated in NSCLC including, PVT1, LINC00152, HOTAIR, H19, UPAT, HOXD-AS1, LINC00339, and MLAT (<xref rid="t1-gi-2018-16-4-e18" ref-type="table">Table 1</xref>).</p>
        <p>The lncRNA plasmacytoma variant translocation 1 (PVT1) was first described in 2013 in human colorectal cancer. PVT1, located at 8q24, has been shown to be regulated in the biological processes of various cancer types, including liver, colon, and ovarian cancers [<xref rid="b20-gi-2018-16-4-e18" ref-type="bibr">20</xref>&#x2013;<xref rid="b22-gi-2018-16-4-e18" ref-type="bibr">22</xref>]. Recent studies have shown that PVT1 expression is positively associated with NSCLC aggressiveness [<xref rid="b23-gi-2018-16-4-e18" ref-type="bibr">23</xref>]. PVT1 promotes cell growth, cancer cell invasion and anti-apoptosis by acting as a ceRNA to sponge miR-195 or miR-497 [<xref rid="b24-gi-2018-16-4-e18" ref-type="bibr">24</xref>, <xref rid="b25-gi-2018-16-4-e18" ref-type="bibr">25</xref>]. In addition, PVT1 upregulates matrix metalloproteinase 9 (MMP9) by acting as a ceRNA to suppress miR-200a/b activity, thereby increasing cancer cell invasion capacity through increased MMP9 expression [<xref rid="b25-gi-2018-16-4-e18" ref-type="bibr">25</xref>]. The oncogenic roles of PVT1 could be supported by the bioinformatics analyses based on the Oncomine database (<ext-link ext-link-type="uri" xlink:href="http://www.oncomine.org/">http://www.oncomine.org/</ext-link>) demonstrating that PVT1 expression was significantly upregulated in lung adenocarcinomas (2.232- and 4.293-fold change) compared to the corresponding normal tissues (<xref ref-type="fig" rid="f3-gi-2018-16-4-e18">Fig. 3</xref>) [<xref rid="b26-gi-2018-16-4-e18" ref-type="bibr">26</xref>, <xref rid="b27-gi-2018-16-4-e18" ref-type="bibr">27</xref>].</p>
        <p>Overexpression of long intergenic ncRNA 152 (LINC00152) promotes the development of NSCLC. One study reported that LINC00152 can upregulate the expression of epidermal growth factor receptor (EGFR), which acts to upregulate tumor cell proliferation by increasing the activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway [<xref rid="b28-gi-2018-16-4-e18" ref-type="bibr">28</xref>]. Moreover, increased expression of LINC00152 increases the protein levels of fibronectin and vimentin and decreases the protein levels of p21, indicating that the expression of LINC00152 is associated with cancer cell invasion and anti-apoptosis. This study was supported by another effort conducting an RNA immunoprecipitation assay with LINC00152 and EGFR [<xref rid="b29-gi-2018-16-4-e18" ref-type="bibr">29</xref>]. It revealed that LINC00152 could bind to EGFR (the potential peptide sequence of EGFR for binding target: MHLPSPTDSNFYR) and might allow EGFR to be phosphorylated for its activation. In addition, an increase in LINC00152 expression can decrease the level of tumor suppressor interleukin-24 by binding to enhancer of zeste homolog 2 (EZH2), which was supported by an RNA immunoprecipitation assay [<xref rid="b30-gi-2018-16-4-e18" ref-type="bibr">30</xref>]. It indicated that LINC00152 expression can promote cell cycle progression and cell proliferation.</p>
      </sec>
      <sec>
        <title>Colorectal cancer</title>
        <p>Colorectal cancer (CRC) is the third leading cause of morbidity and, after lung cancer, the second leading cause of cancer-related deaths in the world [<xref rid="b17-gi-2018-16-4-e18" ref-type="bibr">17</xref>]. In recent decades, many studies of CRC have revealed several tumor-associated molecular markers, such as PI3K, BRAF, and KRAS [<xref rid="b31-gi-2018-16-4-e18" ref-type="bibr">31</xref>]. Despite advances in treatment therapies, survival rates have remained less than 50% due to insufficient therapeutic tolerance [<xref rid="b32-gi-2018-16-4-e18" ref-type="bibr">32</xref>]. The lncRNAs that have been associated with CRC include SNHG1, GAPLINC, TP73-AS1, CASC15, SOX21-AS1, ZEB1-AS1, DLEU1, and LINC00174 (<xref rid="t2-gi-2018-16-4-e18" ref-type="table">Table 2</xref>).</p>
        <p>Small nucleolar RNA host gene 1 (SNHG1) is reported to improve cancer cell proliferation and invasion in CRC. In addition, SNHG1 can function as a sponge of miR-145 leading to block the expression of miR-145 [<xref rid="b33-gi-2018-16-4-e18" ref-type="bibr">33</xref>], which has targets associated with tumorigenesis including insulin-like growth factor 1 receptor and p21-activated kinase 4 [<xref rid="b34-gi-2018-16-4-e18" ref-type="bibr">34</xref>]. Moreover, expression of SNHG1 promotes activation of the Wnt/<italic>&#x3B2;</italic>-catenin signaling pathway by direct binding to and inhibiting miR-302/372/373/520, leading to CRC cell proliferation [<xref rid="b35-gi-2018-16-4-e18" ref-type="bibr">35</xref>, <xref rid="b36-gi-2018-16-4-e18" ref-type="bibr">36</xref>]. The oncogenic roles of SNHG1 could be supported by the bioinformatics analyses based on the colon and rectum adenocarcinoma gene expression data conducted by The Cancer Genome Atlas deposited in Oncomine database demonstrating that SNHG1 expression was significantly upregulated in cecum adenocarcinomas (2.697-fold change), rectal adenocarcinomas (3.333-fold change), colon adenocarcinomas (2.806-fold change), and colon mucinous adenocarcinomas (2.241-fold change) compared to the corresponding normal tissues (<xref ref-type="fig" rid="f4-gi-2018-16-4-e18">Fig. 4</xref>).</p>
        <p>The expression of gastric adenocarcinoma predictive long intergenic non-coding (GAPLINC) is upregulated in CRC. GAPLINC can directly bind to PTB-associated splicing factor and non-POU-domain-containing octamer-binding protein supported by RNA pull-down assays, which lead to upregulation of SNAI2 expression and subsequent induction of cancer cell invasion [<xref rid="b37-gi-2018-16-4-e18" ref-type="bibr">37</xref>]. In addition, GAPLINCR can downregulate miR-34a by acting as a ceRNA, resulting in increased levels of a proto-oncogene c-MET (a target of miR-34a), which is associated with invasion by and migration of cancer cells [<xref rid="b38-gi-2018-16-4-e18" ref-type="bibr">38</xref>].</p>
      </sec>
      <sec>
        <title>Glioblastoma</title>
        <p>Glioma, which is present in more than 30% of brain cancer patients, is one of the cancers with the poorest prognosis [<xref rid="b39-gi-2018-16-4-e18" ref-type="bibr">39</xref>]. Despite the advancements in technology and therapeutic approaches for glioma treatment, its prognosis is poor and recurrence of glioma progression might be unavoidable [<xref rid="b40-gi-2018-16-4-e18" ref-type="bibr">40</xref>]. Gliomas are sub-divided into grades II&#x2013;IV with glioblastomas (GBM), with the highest grade, having a high risk of invasion and recurrence [<xref rid="b41-gi-2018-16-4-e18" ref-type="bibr">41</xref>, <xref rid="b42-gi-2018-16-4-e18" ref-type="bibr">42</xref>]. Despite many studies investigating strategies for surgery, radiotherapy, and chemotherapy of GBM, the survival period for patients with GBM is short [<xref rid="b43-gi-2018-16-4-e18" ref-type="bibr">43</xref>]. The lncRNAs that have been associated with GBM include NEAT1, DANCR, lncHERG, SNHG7, MNX1-AS1, MCM3AP-AS1, and LINC01446 (<xref rid="t3-gi-2018-16-4-e18" ref-type="table">Table 3</xref>).</p>
        <p>The expression of nuclear paraspeckle assembly transcript 1 (NEAT1) is higher in GBM cells than in normal brain cells. NEAT1 act as a sponge of miR-449b-5p, leading to downregulation of the miRNA expression [<xref rid="b44-gi-2018-16-4-e18" ref-type="bibr">44</xref>]. Consequently, the expression of c-Met, which has a tumorigenic role and is a molecular target of miR-449b-5p, is increased. Another study has presented that NEAT1 can also act as a ceRNA for miR-132 inhibition, which lead to increase of oncogene SOX2 expression and subsequent induction of cell proliferation, invasion, and migration in glioma cells [<xref rid="b45-gi-2018-16-4-e18" ref-type="bibr">45</xref>]. The oncogenic roles of NEAT1 could be supported by the bioinformatics analyses based on the Oncomine database demonstrating that NEAT1 expression was significantly upregulated in GBM (5.286- and 4.887-fold change) compared to the corresponding normal brain tissues (<xref ref-type="fig" rid="f5-gi-2018-16-4-e18">Fig. 5</xref>) [<xref rid="b46-gi-2018-16-4-e18" ref-type="bibr">46</xref>, <xref rid="b47-gi-2018-16-4-e18" ref-type="bibr">47</xref>].</p>
        <p>Differentiation antagonizing non-protein coding RNA (DANCR) is another oncogenic lncRNA present in GBM cells. DANCR is reported to inhibit several tumor-suppressive miRNAs including miR-33b-5p, miR-1-3p, miR-206, and miR-613 by functioning as a ceRNA [<xref rid="b48-gi-2018-16-4-e18" ref-type="bibr">48</xref>]. Inhibition of these miRs by DANCR is associated with activation of AXL/PI3K/Akt/NF-<italic>&#x3BA;</italic>B signaling. Another study has demonstrated that DANCR can activate Wnt/<italic>&#x3B2;</italic>-catenin signaling although further study for identification of potential DANCR targets on Wnt/<italic>&#x3B2;</italic>-catenin signaling would be required [<xref rid="b49-gi-2018-16-4-e18" ref-type="bibr">49</xref>]. These effects of DANCR is responsible for cell proliferation, anti-apoptosis, and cell migration functions, and, as a consequence, contributes to chemoresistance in GBM therapy.</p>
      </sec>
      <sec>
        <title>Breast cancer</title>
        <p>Breast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer death in women [<xref rid="b17-gi-2018-16-4-e18" ref-type="bibr">17</xref>]. Despite many studies into therapeutic technologies and strategies for BC in recent decades, BC remains among the leading causes of morbidity and mortality worldwide [<xref rid="b50-gi-2018-16-4-e18" ref-type="bibr">50</xref>]. The lncRNAs associated with BC include MALAT1, CCAT2, PRLB, SUMO1P3, LINC00518, ITGB2-AS1, ARNILA, and PANDAR (<xref rid="t4-gi-2018-16-4-e18" ref-type="table">Table 4</xref>).</p>
        <p>Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is one of the oncogenic lncRNAs related to BC. Overexpression of MALAT1 activates cyclin-dependent kinase 4 (CDK4) by functioning as a ceRNA for inhibition of miR-124 expression [<xref rid="b51-gi-2018-16-4-e18" ref-type="bibr">51</xref>]. Since CDK4 is a major regulator of the cell cycle and E2F1 is a downstream target of CDK4, CDK4/E2F1 signaling activated by MALAT1 is closely associated with cell cycle progression and cancer cell proliferation. Another study has presented that MALAT1 can also act as a ceRNA to sponge miR-204 [<xref rid="b52-gi-2018-16-4-e18" ref-type="bibr">52</xref>]. Decreased miR-204 can upregulate the expression of zinc finger E-box binding homeobox 2, thereby increasing epithelial-mesenchymal transition capacity and BC cell invasion. The oncogenic roles of MALAT1 could be supported by the bioinformatics analyses based on the Oncomine database demonstrating that MALAT1 expression was significantly upregulated in invasive ductal breast carcinomas (2.600- and 2.166-fold change) compared to the corresponding normal breast tissues (<xref ref-type="fig" rid="f6-gi-2018-16-4-e18">Fig. 6</xref>) [<xref rid="b53-gi-2018-16-4-e18" ref-type="bibr">53</xref>, <xref rid="b54-gi-2018-16-4-e18" ref-type="bibr">54</xref>].</p>
        <p>Colon cancer-associated transcript 2 (CCAT2) is one of the lncRNAs which expression is higher in BC cells than in normal breast cells. CCAT2 can decrease tumor suppressor p15 by direct interaction with EZH2, which supported by an RNA immunoprecipitation assay [<xref rid="b55-gi-2018-16-4-e18" ref-type="bibr">55</xref>]. Based on this effect of CCAT2, overexpressed CCAT2 can indirectly increase cell cycle-associated proteins including cyclin D1, cyclin E1, and CDK4, thereby promoting BC cell proliferation. Other study have reported that upregulated CCAT2 can induce cell growth, invation, metastasis, and anti-apoptosis in BC cells through its ability to regulate the transforming growth factor <italic>&#x3B2;</italic>/SMAD signaling and Wnt/<italic>&#x3B2;</italic>-catenin signaling although specific targets of CCAT2 on both signaling pathways have remained unclear [<xref rid="b56-gi-2018-16-4-e18" ref-type="bibr">56</xref>, <xref rid="b57-gi-2018-16-4-e18" ref-type="bibr">57</xref>].</p>
      </sec>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Initially, ncRNAs, which do not encode proteins, were referred to as noise or junk DNA. However, interest in ncRNAs increased following the completion of the Human Genome Project. Since then, the study of ncRNAs has gradually become a central research area in RNA biology. As the amount of research on ncRNAs continues to grow, the importance of the non-protein-coding part of the human genome has been highlighted. In addition, with the revealing of several important roles of lncRNAs <italic>in vivo</italic>, interest in lncRNAs has increased. Research into the roles of lncRNAs has presented a new direction for research into tumorigenic mechanisms and cancer therapies. In general, an increase in lncRNAs expression is observed to be highly correlated to the incidence of cancer. In addition, upregulated lncRNAs contribute to the promotion of many biological processes associated with cancer development such as cell cycle progression as well as cell proliferation, invasion, metastasis, and chemoresistance. Despite the findings of many lncRNA-related studies, there are still many obstacles to fully elucidating the functions of lncRNAs. Regardless, future lncRNA studies are expected to reveal and describe the regulatory networks and molecular characteristics of human cancers. Elucidation of the relationships between oncogenic lncRNAs and tumorigenesis may be helpful for in the development of deeper insights into cancer prevention and treatment.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Authors&#x2019; contribution:</bold>
        </p>
        <p>Conceptualization: WK</p>
        <p>Data curation: HD, WK</p>
        <p>Formal analysis: HD, WK</p>
        <p>Methodology: HD, WK</p>
        <p>Writing &#x2013; original draft: HD, WK</p>
        <p>Writing &#x2013; review &amp; editing: HD, WK</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>
          <bold>Conflict of interest</bold>
        </p>
        <p>No potential conflicts of interest relevant to this article was reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-gi-2018-16-4-e18">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>International Human Genome Sequencing Consortium</collab>
          </person-group>
          <article-title>Finishing the euchromatic sequence of the human genome</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>431</volume>
          <fpage>931</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">15496913</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-gi-2018-16-4-e18">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Derrien</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bussotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tanzer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Djebali</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tilgner</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression</article-title>
          <source>Genome Res</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>1775</fpage>
          <lpage>1789</lpage>
          <pub-id pub-id-type="pmid">22955988</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-gi-2018-16-4-e18">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>FY</given-names>
            </name>
            <name>
              <surname>Chinnaiyan</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>The bright side of dark matter: lncRNAs in cancer</article-title>
          <source>J Clin Invest</source>
          <year>2016</year>
          <volume>126</volume>
          <fpage>2775</fpage>
          <lpage>2782</lpage>
          <pub-id pub-id-type="pmid">27479746</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-gi-2018-16-4-e18">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA: a new player in cancer</article-title>
          <source>J Hematol Oncol</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>37</fpage>
          <pub-id pub-id-type="pmid">23725405</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-gi-2018-16-4-e18">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ponting</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Reik</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Evolution and functions of long noncoding RNAs</article-title>
          <source>Cell</source>
          <year>2009</year>
          <volume>136</volume>
          <fpage>629</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="pmid">19239885</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-gi-2018-16-4-e18">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kotake</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Niida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohhata</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cell cycle regulation by long non-coding RNAs</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2013</year>
          <volume>70</volume>
          <fpage>4785</fpage>
          <lpage>4794</lpage>
          <pub-id pub-id-type="pmid">23880895</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-gi-2018-16-4-e18">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khorshidi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dhaliwal</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Noncoding RNAs in tumor angiogenesis</article-title>
          <source>Adv Exp Med Biol</source>
          <year>2016</year>
          <volume>927</volume>
          <fpage>217</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">27376737</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-gi-2018-16-4-e18">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>XH</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNAs in cancer invasion and metastasis</article-title>
          <source>Mod Pathol</source>
          <year>2015</year>
          <volume>28</volume>
          <fpage>4</fpage>
          <lpage>13</lpage>
        </element-citation>
      </ref>
      <ref id="b9-gi-2018-16-4-e18">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Qing</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Regulatory roles of long non-coding RNAs in the central nervous system and associated neurodegenerative diseases</article-title>
          <source>Front Cell Neurosci</source>
          <year>2017</year>
          <volume>11</volume>
          <fpage>175</fpage>
          <pub-id pub-id-type="pmid">28713244</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-gi-2018-16-4-e18">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thum</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy</article-title>
          <source>Circulation</source>
          <year>2016</year>
          <volume>134</volume>
          <fpage>1484</fpage>
          <lpage>1499</lpage>
          <pub-id pub-id-type="pmid">27821419</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-gi-2018-16-4-e18">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease</article-title>
          <source>Endocr Rev</source>
          <year>2015</year>
          <volume>36</volume>
          <fpage>25</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">25426780</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-gi-2018-16-4-e18">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nobili</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ronchetti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Taiana</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Neri</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNAs in B-cell malignancies: a comprehensive overview</article-title>
          <source>Oncotarget</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>60605</fpage>
          <lpage>60623</lpage>
          <pub-id pub-id-type="pmid">28947998</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-gi-2018-16-4-e18">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Goff</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNAs: central to nervous system development</article-title>
          <source>Int J Dev Neurosci</source>
          <year>2016</year>
          <volume>55</volume>
          <fpage>109</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">27296516</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-gi-2018-16-4-e18">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Leng</surname>
              <given-names>RX</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>XP</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>XM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emerging role of long noncoding RNAs in autoimmune diseases</article-title>
          <source>Autoimmun Rev</source>
          <year>2015</year>
          <volume>14</volume>
          <fpage>798</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="pmid">25989481</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-gi-2018-16-4-e18">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gibbons</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Udawela</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Non-coding RNA as novel players in the pathophysiology of schizophrenia</article-title>
          <source>Noncoding RNA</source>
          <year>2018</year>
          <volume>4</volume>
          <fpage>E11</fpage>
          <pub-id pub-id-type="pmid">29657307</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-gi-2018-16-4-e18">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bie</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNAs: critical players in hepatocellular carcinoma</article-title>
          <source>Int J Mol Sci</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>20434</fpage>
          <lpage>20448</lpage>
          <pub-id pub-id-type="pmid">25387074</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-gi-2018-16-4-e18">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Jemal</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cancer statistics, 2017</article-title>
          <source>CA Cancer J Clin</source>
          <year>2017</year>
          <volume>67</volume>
          <fpage>7</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">28055103</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-gi-2018-16-4-e18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldstraw</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jett</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Le Chevalier</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-small-cell lung cancer</article-title>
          <source>Lancet</source>
          <year>2011</year>
          <volume>378</volume>
          <fpage>1727</fpage>
          <lpage>1740</lpage>
          <pub-id pub-id-type="pmid">21565398</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-gi-2018-16-4-e18">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alvarez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Raez</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>New targets for non-small-cell lung cancer therapy</article-title>
          <source>Expert Rev Anticancer Ther</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>1423</fpage>
          <lpage>1437</lpage>
          <pub-id pub-id-type="pmid">17944567</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-gi-2018-16-4-e18">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>XQ</given-names>
            </name>
          </person-group>
          <article-title>Knockdown of long noncoding RNA PVT1 reverses multidrug resistance in colorectal cancer cells</article-title>
          <source>Mol Med Rep</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>8309</fpage>
          <lpage>8315</lpage>
          <pub-id pub-id-type="pmid">29693171</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-gi-2018-16-4-e18">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer</article-title>
          <source>Biomed Pharmacother</source>
          <year>2018</year>
          <volume>106</volume>
          <fpage>61</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">29957467</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-gi-2018-16-4-e18">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2</article-title>
          <source>Cancer Cell Int</source>
          <year>2018</year>
          <volume>18</volume>
          <fpage>98</fpage>
          <pub-id pub-id-type="pmid">30008615</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-gi-2018-16-4-e18">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The prognostic value of long non coding RNAs in non small cell lung cancer: a meta-analysis</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>81292</fpage>
          <lpage>81304</lpage>
          <pub-id pub-id-type="pmid">27833074</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-gi-2018-16-4-e18">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression</article-title>
          <source>Exp Cell Res</source>
          <year>2018</year>
          <volume>362</volume>
          <fpage>172</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">29133127</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-gi-2018-16-4-e18">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>lncRNA-PVT1 facilitates invasion through upregulation of MMP9 in non-small cell lung cancer cell</article-title>
          <source>DNA Cell Biol</source>
          <year>2017</year>
          <volume>36</volume>
          <fpage>787</fpage>
          <lpage>793</lpage>
          <pub-id pub-id-type="pmid">28731781</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-gi-2018-16-4-e18">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garber</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Troyanskaya</surname>
              <given-names>OG</given-names>
            </name>
            <name>
              <surname>Schluens</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thaesler</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Pacyna-Gengelbach</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diversity of gene expression in adenocarcinoma of the lung</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>13784</fpage>
          <lpage>13789</lpage>
          <pub-id pub-id-type="pmid">11707590</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-gi-2018-16-4-e18">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stearman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Dwyer-Nield</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zerbe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blaine</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Bunn</surname>
              <given-names>PA</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model</article-title>
          <source>Am J Pathol</source>
          <year>2005</year>
          <volume>167</volume>
          <fpage>1763</fpage>
          <lpage>1775</lpage>
          <pub-id pub-id-type="pmid">16314486</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-gi-2018-16-4-e18">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway</article-title>
          <source>Biomed Pharmacother</source>
          <year>2017</year>
          <volume>94</volume>
          <fpage>644</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="pmid">28787699</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-gi-2018-16-4-e18">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhi</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway</article-title>
          <source>J Exp Clin Cancer Res</source>
          <year>2015</year>
          <volume>34</volume>
          <fpage>135</fpage>
          <pub-id pub-id-type="pmid">26538117</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-gi-2018-16-4-e18">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>QN</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Nie</surname>
              <given-names>FQ</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>HW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression</article-title>
          <source>Mol Cancer</source>
          <year>2017</year>
          <volume>16</volume>
          <fpage>17</fpage>
          <pub-id pub-id-type="pmid">28109288</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-gi-2018-16-4-e18">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>XY</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Threapleton</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>YY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Concordant analysis of <italic>KRAS, BRAF, PIK3CA</italic> mutations, and PTEN expression between primary colorectal cancer and matched metastases</article-title>
          <source>Sci Rep</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>8065</fpage>
          <pub-id pub-id-type="pmid">25639985</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-gi-2018-16-4-e18">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Misale</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yaeger</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hobor</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Scala</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Janakiraman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liska</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emergence of <italic>KRAS</italic> mutations and acquired resistance to anti-EGFR therapy in colorectal cancer</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>486</volume>
          <fpage>532</fpage>
          <lpage>536</lpage>
          <pub-id pub-id-type="pmid">22722830</pub-id>
        </element-citation>
      </ref>
      <ref id="b33-gi-2018-16-4-e18">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer</article-title>
          <source>Oncotarget</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>2128</fpage>
          <lpage>2139</lpage>
          <pub-id pub-id-type="pmid">29416759</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-gi-2018-16-4-e18">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheng</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway</article-title>
          <source>Cancer Med</source>
          <year>2017</year>
          <volume>6</volume>
          <fpage>1331</fpage>
          <lpage>1340</lpage>
          <pub-id pub-id-type="pmid">28440035</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-gi-2018-16-4-e18">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lv</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/beta-catenin signaling pathway</article-title>
          <source>Oncotarget</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>111715</fpage>
          <lpage>111727</lpage>
          <pub-id pub-id-type="pmid">29340086</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-gi-2018-16-4-e18">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lnc-SNHG1 activates the TGFBR2/SMAD3 and RAB11A/Wnt/beta-catenin pathway by sponging MiR-302/372/373/520 in invasive pituitary tumors</article-title>
          <source>Cell Physiol Biochem</source>
          <year>2018</year>
          <volume>48</volume>
          <fpage>1291</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="pmid">30048990</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-gi-2018-16-4-e18">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>42183</fpage>
          <lpage>42194</lpage>
          <pub-id pub-id-type="pmid">27259250</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-gi-2018-16-4-e18">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ou</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long noncoding RNA GAPLINC promotes cells migration and invasion in colorectal cancer cell by regulating miR-34a/c-MET signal pathway</article-title>
          <source>Dig Dis Sci</source>
          <year>2018</year>
          <volume>63</volume>
          <fpage>890</fpage>
          <lpage>899</lpage>
          <pub-id pub-id-type="pmid">29427222</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-gi-2018-16-4-e18">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mitra</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Eischen</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development</article-title>
          <source>Mol Cancer Ther</source>
          <year>2016</year>
          <volume>15</volume>
          <fpage>2977</fpage>
          <lpage>2986</lpage>
          <pub-id pub-id-type="pmid">27784795</pub-id>
        </element-citation>
      </ref>
      <ref id="b40-gi-2018-16-4-e18">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Current and future drug treatments for glioblastomas</article-title>
          <source>Curr Med Chem</source>
          <year>2016</year>
          <volume>23</volume>
          <fpage>4309</fpage>
          <lpage>4316</lpage>
          <pub-id pub-id-type="pmid">27758718</pub-id>
        </element-citation>
      </ref>
      <ref id="b41-gi-2018-16-4-e18">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grant</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kolb</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Moliterno</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Molecular and genetic pathways in gliomas: the future of personalized therapeutics</article-title>
          <source>CNS Oncol</source>
          <year>2014</year>
          <volume>3</volume>
          <fpage>123</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">25055018</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-gi-2018-16-4-e18">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Car&#xE9;n</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pollard</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The good, the bad and the ugly: epigenetic mechanisms in glioblastoma</article-title>
          <source>Mol Aspects Med</source>
          <year>2013</year>
          <volume>34</volume>
          <fpage>849</fpage>
          <lpage>862</lpage>
          <pub-id pub-id-type="pmid">22771539</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-gi-2018-16-4-e18">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bastien</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>McNeill</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Fine</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date</article-title>
          <source>Cancer</source>
          <year>2015</year>
          <volume>121</volume>
          <fpage>502</fpage>
          <lpage>516</lpage>
          <pub-id pub-id-type="pmid">25250735</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-gi-2018-16-4-e18">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yun-Hui</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hong-Yu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yi-Long</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis</article-title>
          <source>Tumour Biol</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>673</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="pmid">26242266</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-gi-2018-16-4-e18">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Che</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132</article-title>
          <source>Mol Cancer</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>105</fpage>
          <pub-id pub-id-type="pmid">30053878</pub-id>
        </element-citation>
      </ref>
      <ref id="b46-gi-2018-16-4-e18">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Vortmeyer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kotliarov</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Pastorino</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain</article-title>
          <source>Cancer Cell</source>
          <year>2006</year>
          <volume>9</volume>
          <fpage>287</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">16616334</pub-id>
        </element-citation>
      </ref>
      <ref id="b47-gi-2018-16-4-e18">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bredel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bredel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Juric</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Harsh</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Recht</surname>
              <given-names>LD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional network analysis reveals extended glioma-genesis pathway maps and three novel MYC-interacting genes in human gliomas</article-title>
          <source>Cancer Res</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>8679</fpage>
          <lpage>8689</lpage>
          <pub-id pub-id-type="pmid">16204036</pub-id>
        </element-citation>
      </ref>
      <ref id="b48-gi-2018-16-4-e18">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-kappaB signaling pathway</article-title>
          <source>Neurochem Int</source>
          <year>2018</year>
          <volume>118</volume>
          <fpage>233</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">29572052</pub-id>
        </element-citation>
      </ref>
      <ref id="b49-gi-2018-16-4-e18">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/beta-catenin signaling</article-title>
          <source>Biomed Pharmacother</source>
          <year>2018</year>
          <volume>102</volume>
          <fpage>602</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">29602127</pub-id>
        </element-citation>
      </ref>
      <ref id="b50-gi-2018-16-4-e18">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Seng</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1</article-title>
          <source>J Cell Mol Med</source>
          <year>2018</year>
          <volume>22</volume>
          <fpage>4068</fpage>
          <lpage>4075</lpage>
          <pub-id pub-id-type="pmid">29971911</pub-id>
        </element-citation>
      </ref>
      <ref id="b51-gi-2018-16-4-e18">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>16205</fpage>
          <lpage>16216</lpage>
          <pub-id pub-id-type="pmid">26918449</pub-id>
        </element-citation>
      </ref>
      <ref id="b52-gi-2018-16-4-e18">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer</article-title>
          <source>Tumour Biol</source>
          <year>2017</year>
          <volume>39</volume>
          <fpage>1010428317690998</fpage>
          <pub-id pub-id-type="pmid">28675122</pub-id>
        </element-citation>
      </ref>
      <ref id="b53-gi-2018-16-4-e18">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karnoub</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Dash</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Vo</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>GW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mesenchymal stem cells within tumour stroma promote breast cancer metastasis</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>449</volume>
          <fpage>557</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="pmid">17914389</pub-id>
        </element-citation>
      </ref>
      <ref id="b54-gi-2018-16-4-e18">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Langerod</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nowels</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Nesland</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Tibshirani</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Different gene expression patterns in invasive lobular and ductal carcinomas of the breast</article-title>
          <source>Mol Biol Cell</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>2523</fpage>
          <lpage>2536</lpage>
          <pub-id pub-id-type="pmid">15034139</pub-id>
        </element-citation>
      </ref>
      <ref id="b55-gi-2018-16-4-e18">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer</article-title>
          <source>Biomed Pharmacother</source>
          <year>2017</year>
          <volume>91</volume>
          <fpage>1160</fpage>
          <lpage>1166</lpage>
          <pub-id pub-id-type="pmid">28531944</pub-id>
        </element-citation>
      </ref>
      <ref id="b56-gi-2018-16-4-e18">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nian</surname>
              <given-names>WQ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-beta signaling pathway</article-title>
          <source>Eur Rev Med Pharmacol Sci</source>
          <year>2017</year>
          <volume>21</volume>
          <fpage>706</fpage>
          <lpage>714</lpage>
          <pub-id pub-id-type="pmid">28272713</pub-id>
        </element-citation>
      </ref>
      <ref id="b57-gi-2018-16-4-e18">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway</article-title>
          <source>Onco Targets Ther</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>2657</fpage>
          <lpage>2664</lpage>
          <pub-id pub-id-type="pmid">26442763</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Illustrations for the classification of long non-coding RNAs.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f1"/>
    </fig>
    <fig id="f2-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>The long non-coding RNA (lncRNA) functions in the nucleus and the cytoplasm.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f2"/>
    </fig>
    <fig id="f3-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Expression levels of PVT1 in non-small cell lung cancers. Datasets obtained from Oncomine demonstrated that lung adenocarcinomas significantly expressed high levels of PVT1 compared to the normal counterparts. (A) Fold change = 2.232, p = 6.13 &#xD7; 10<sup>&#x2212;8</sup> [<xref rid="b26-gi-2018-16-4-e18" ref-type="bibr">26</xref>]. (B) Fold change = 4.293, p = 1.45 &#xD7; 10<sup>&#x2212;5</sup> [<xref rid="b27-gi-2018-16-4-e18" ref-type="bibr">27</xref>]. PVT1, plasmacytoma variant translocation 1.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f3"/>
    </fig>
    <fig id="f4-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 4</label>
      <caption>
        <p>Expression levels of SNHG1 in colorectal cancers. Datasets obtained from Oncomine demonstrated that cecum adenocarcinomas (A) (fold change = 2.697, p = 5.22 &#xD7; 10<sup>&#x2212;14</sup>), rectal adenocarcinomas (B) (fold change = 3.333, p = 1.08 &#xD7; 10<sup>&#x2212;21</sup>), colon adenocarcinomas (C) (fold change = 2.806, p = 2.31 &#xD7; 10<sup>&#x2212;19</sup>), and colon mucinous adenocarcinomas (D) (fold change = 2.241, p = 1.10 &#xD7; 10<sup>&#x2212;10</sup>) significantly expressed high levels of PVT1 compared to the normal counterparts. SNHG1, small nucleolar RNA host gene 1; PVT1, plasmacytoma variant translocation 1.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f4"/>
    </fig>
    <fig id="f5-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 5</label>
      <caption>
        <p>Expression levels of NEAT1 in glioblastomas. Datasets obtained from Oncomine demonstrated that GBM significantly expressed high levels of NEAT1 compared to the normal counterparts. (A) Fold change = 5.286, p = 3.18 &#xD7; 10<sup>&#x2212;14</sup> [<xref rid="b46-gi-2018-16-4-e18" ref-type="bibr">46</xref>]. (B) Fold change = 4.887, p = 1.15 &#xD7; 10<sup>&#x2212;11</sup> [<xref rid="b47-gi-2018-16-4-e18" ref-type="bibr">47</xref>]. NEAT1, nuclear paraspeckle assembly transcript 1; GBM, glioblastomas.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f5"/>
    </fig>
    <fig id="f6-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Fig. 6</label>
      <caption>
        <p>Expression levels of MALAT1 in breast cancers. Datasets obtained from Oncomine demonstrated that invasive ductal breast carcinomas significantly expressed high levels of MALAT1 compared to the normal counterparts. (A) Fold change = 2.600, p = 2.45 &#xD7; 10<sup>&#x2212;6</sup> [<xref rid="b53-gi-2018-16-4-e18" ref-type="bibr">53</xref>]. (B) Fold change = 2.166, p = 6.14 &#xD7; 10<sup>&#x2212;4</sup> [<xref rid="b54-gi-2018-16-4-e18" ref-type="bibr">54</xref>]. MALAT1, metastasis-associated lung adenocarcinoma transcript 1.</p>
      </caption>
      <graphic xlink:href="gi-2018-16-4-e18f6"/>
    </fig>
    <table-wrap id="t1-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Oncogenic lncRNAs in non-small cell lung cancers</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="center" rowspan="1" colspan="1">lncRNA</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Mechanism of tumorigenesis</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Biological activity</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Reference PMID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">PVT1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-195</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28848163]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-497</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell growth, invasion, and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29133127]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of MMP9 via sponging miR-200a and miR-200b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28731781]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC00152</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of EGFR/PI3K/Akt signaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28787699]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of fibronectin and vimentin and decrease of p21</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of IL24 via interaction with EZH2</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, cell cycle, and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28109288]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">HOTAIR</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-613</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29187267]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">H19</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of STAT3 via sponging miR-17</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell growth, migration, and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29693721]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">UPAT</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of RASSF1 and CDH13 via increasing UHRF1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30008828]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">HOXD-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of MMP9 via sponging miR-133b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell migration and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29958139]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC00339</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of FOXM1 via sponging miR-145</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29906749]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MIAT</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of MMP9 via interaction with MLL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, cell cycle, migration, and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29228680]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-gi-2018-16-4-e18">
          <p>lncRNA, long non-coding RNAs.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t2-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <p>Oncogenic lncRNAs in colorectal cancers</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="center" rowspan="1" colspan="1">lncRNA</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Mechanism of tumorigenesis</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Biological activity</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Reference PMID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">SNHG1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-145</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29416759]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of WNT/<italic>&#x3B2;</italic>-catenin signaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29340086]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">GAPLINC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of SNAI2 via interaction with PSF and NONO</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[27259250]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of c-MET via sponging miR-34a</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29427222]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">TP73-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of TGF<italic>&#x3B1;</italic> via sponging miR-194</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, migration, and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30010111]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">CASC15</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of LGR5 via sponging miR-4310, leading to activation of Wnt/<italic>&#x3B2;</italic>-catenin signaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and metastasis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29956772]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">SOX21-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of MYO6 via sponging miR-145</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell growth, proliferation, and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29217166]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ZEB1-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of Wnt/<italic>&#x3B2;</italic>-catenin signaling via sponging miR-181a-5p</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29886791]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">DLEU1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of KPNA3 via interaction with SMARCA1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30098595]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC00174</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of TAZ via sponging miR-1910-3p</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29729381]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn2-gi-2018-16-4-e18">
          <p>lncRNA, long non-coding RNAs.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t3-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Table 3</label>
      <caption>
        <p>Oncogenic lncRNAs in glioblastomas</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="center" rowspan="1" colspan="1">lncRNA</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Mechanism of tumorigenesis</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Biological activity</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Reference PMID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">NEAT1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of c-Met via sponging miR-449b-5p</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[26242266]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of SOX2 via sponging miR-132</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30053878]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">DANCR</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of AXL via sponging miR-33a-5p, miR-33b-5p, miR-1-3p, miR-206, and miR-613, leading to activation of PI3K/Akt/NF-<italic>&#x3BA;</italic>B signaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Anti-apoptosis and chemoresistance</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29572052]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of Wnt/<italic>&#x3B2;</italic>-cateninsignaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29602127]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">lncHERG</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-940</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29296221]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC00958</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of CDK2 via sponging miR-203</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29570358]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">SNHG7</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-5095</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, migration, and anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29360452]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MCM3AP-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of KLF5 via sponging miR-211, leading to activation of AGGF1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Angiogenesis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29375300]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MNX1-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-4443</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29678219]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC01446</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of TPT1 via sponging miR-489-3p</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30029885]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn3-gi-2018-16-4-e18">
          <p>lncRNA, long non-coding RNAs.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t4-gi-2018-16-4-e18" orientation="portrait" position="float">
      <label>Table 4</label>
      <caption>
        <p>Oncogenic lncRNAs in breast cancers</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="center" rowspan="1" colspan="1">lncRNA</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Mechanism of tumorigenesis</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Biological activity</th>
            <th valign="middle" align="center" rowspan="1" colspan="1">Reference PMID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MALAT1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of CDK4/E2F1 pathway via sponging miR-124</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferationand cell cycle</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[26918449]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of ZEB2 via sponging miR-204</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28675122]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">CCAT2</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of p15 via interacting with EZH2</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[28531944]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of Wnt/<italic>&#x3B2;</italic>-catenin signaling pathway</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and invasion</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[26442763]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">PRLB</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of SIRT1 via sponging miR-4766-5p</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29752439]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">SUMO1P3</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of miR-320a</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation, invasion, and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29312511]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LINC00518</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of MRP1 via sponging miR-199a</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Anti-apoptosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[30001527]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ITGB2-AS1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of ITGB2, leading to activation of FAK signaling</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell invasion and migration</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29941860]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ARNILA</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Activation of Sox4 via sponging miR-204</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Epithelial-mesenchymal transition</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[29844570]</td>
          </tr>
          <tr>
            <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">PANDAR</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Decrease of p16I<sup>NK4A</sup> via binding to Bmi1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Cell proliferation and G1/S transition</td>
            <td valign="top" align="center" rowspan="1" colspan="1">[26927017]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn4-gi-2018-16-4-e18">
          <p>lncRNA, long non-coding RNAs.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>